103 related articles for article (PubMed ID: 27685922)
1. Expression of CDCP1 and ADAM12 in the ovarian cancer microenvironment.
Vlad C; Kubelac P; Onisim A; Fetica B; Fulop A; Irimie A; Achimas-Cadariu P
J BUON; 2016; 21(4):973-978. PubMed ID: 27685922
[TBL] [Abstract][Full Text] [Related]
2. The role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancer.
Vlad C; Kubelac P; Onisim A; Irimie A; Achimas-Cadariu P
J BUON; 2015; 20(3):673-9. PubMed ID: 26214617
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.
Mamat S; Ikeda J; Enomoto T; Ueda Y; Rahadiani N; Tian T; Wang Y; Qiu Y; Kimura T; Aozasa K; Morii E
Oncol Rep; 2010 May; 23(5):1221-7. PubMed ID: 20372833
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of microvessel density in ovarian cancer].
Rossochacka-Rostalska B; Gisterek IJ; Suder E; Szelachowska JK; Matkowski RA; Lacko A; Kornafel JA
Wiad Lek; 2007; 60(3-4):129-37. PubMed ID: 17726864
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
7. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
9. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
[TBL] [Abstract][Full Text] [Related]
10. Novel surface targets and serum biomarkers from the ovarian cancer vasculature.
Sasaroli D; Gimotty PA; Pathak HB; Hammond R; Kougioumtzidou E; Katsaros D; Buckanovich R; Devarajan K; Sandaltzopoulos R; Godwin AK; Scholler N; Coukos G
Cancer Biol Ther; 2011 Aug; 12(3):169-80. PubMed ID: 21617380
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
12. Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.
Sawada G; Takahashi Y; Niida A; Shimamura T; Kurashige J; Matsumura T; Ueo H; Uchi R; Takano Y; Ueda M; Hirata H; Sakimura S; Shinden Y; Eguchi H; Sudo T; Sugimachi K; Miyano S; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S640-7. PubMed ID: 24849519
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
He L; Wang Q; Zhao X
Asian Pac J Cancer Prev; 2015; 16(3):869-74. PubMed ID: 25735375
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
[TBL] [Abstract][Full Text] [Related]
17. CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F; Bianchi F; Gasparini P; Sandri M; Sasso M; De Cecco L; Forte L; Casalini P; Aiello P; Sfondrini L; Agresti R; Carcangiu ML; Plantamura I; Sozzi G; Tagliabue E; Campiglio M
Oncotarget; 2016 Oct; 7(43):69649-69665. PubMed ID: 27626701
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
[TBL] [Abstract][Full Text] [Related]
19. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]